rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0002458,
umls-concept:C0004238,
umls-concept:C0007189,
umls-concept:C0013865,
umls-concept:C0030705,
umls-concept:C0050451,
umls-concept:C0086047,
umls-concept:C0162458,
umls-concept:C0162791,
umls-concept:C0175754,
umls-concept:C0239307,
umls-concept:C0242456,
umls-concept:C0282116,
umls-concept:C0282160,
umls-concept:C0425358,
umls-concept:C0557806,
umls-concept:C0684224,
umls-concept:C0936005,
umls-concept:C1273870,
umls-concept:C1706244,
umls-concept:C1851476,
umls-concept:C2699414,
umls-concept:C2700615
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-10-3
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0735-1097
|
pubmed:author |
pubmed-author:Alonso-GarciaAA,
pubmed-author:AlpertJ SJS,
pubmed-author:American College of Cardiology/American Heart Association/European...,
pubmed-author:AntmanE MEM,
pubmed-author:AsingerR WRW,
pubmed-author:Blomström-LundqvistCC,
pubmed-author:CannonD RDR,
pubmed-author:CrijnsH JHJ,
pubmed-author:De BackerGG,
pubmed-author:FaxonD PDP,
pubmed-author:FlatherMM,
pubmed-author:FryeR LRL,
pubmed-author:FusterVV,
pubmed-author:GibbonsR JRJ,
pubmed-author:GregoratosGG,
pubmed-author:HalperinJ LJL,
pubmed-author:HiratzkaL FLF,
pubmed-author:HradecJJ,
pubmed-author:JacobsA KAK,
pubmed-author:KayG NGN,
pubmed-author:KleinW WWW,
pubmed-author:LévySS,
pubmed-author:McNamaraR LRL,
pubmed-author:OtoAA,
pubmed-author:ParkhomenkoAA,
pubmed-author:PrystowskyE NEN,
pubmed-author:RussellR ORO,
pubmed-author:RydénL ELE,
pubmed-author:SilberSS,
pubmed-author:SmithS CSC,
pubmed-author:TorbickiAA,
pubmed-author:WannL SLS,
pubmed-author:WyseD GDG
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1231-66
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11583910-Algorithms,
pubmed-meshheading:11583910-Anti-Arrhythmia Agents,
pubmed-meshheading:11583910-Anticoagulants,
pubmed-meshheading:11583910-Atrial Fibrillation,
pubmed-meshheading:11583910-Catheter Ablation,
pubmed-meshheading:11583910-Electric Countershock,
pubmed-meshheading:11583910-Heart Catheterization,
pubmed-meshheading:11583910-Heart Rate,
pubmed-meshheading:11583910-Hemodynamics,
pubmed-meshheading:11583910-Humans,
pubmed-meshheading:11583910-International Normalized Ratio,
pubmed-meshheading:11583910-Quality of Life,
pubmed-meshheading:11583910-Risk Assessment,
pubmed-meshheading:11583910-Thromboembolism,
pubmed-meshheading:11583910-Warfarin,
pubmed-meshheading:11583910-Wolff-Parkinson-White Syndrome
|
pubmed:year |
2001
|
pubmed:articleTitle |
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.
|
pubmed:publicationType |
Journal Article,
Guideline,
Practice Guideline
|